Background
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial membrane inflammation [
1,
2]. Erosive joint damage and bone destruction are the most common manifestation of RA, which might induce ankylosis, malformation, even loss of normal joint function [
3,
4]. Current goals of treatment in RA include achieving disease remission, reducing functional disability as well as minimizing pain [
5,
6]. Erosions are the hallmark of bone destruction in RA [
7,
8]. Controlling joint destruction and bone destruction have become the major objective for treating RA, because radiographic joint damage correlates strongly with long-term functional decline in RA patients [
9,
10]. Radiographic grading of hands is the most commonly used method for the evaluation of different levels of bone erosion in clinical practice [
11,
12]. Bone erosion score (vdH sharp score) has also been used to measure morphological parameters that quantify the bone erosion and bone destruction, giving useful information for early detection and early treatment of RA [
13,
14]. Few studies to date have studied the overall impact of RA on sharp score and its effective factors. In addition, there has been no study that looks for effective factors associated with sharp score of RA on the basis of large data by doing the mining and analysis of this data.
This study retrospectively analyzed the clinical data of enrolled patients to investigate the value of sharp score and its effective factors in RA. The Spearman correlation analysis, Association rules analysis and Logistic regression analysis are methods of analysis that allows for the identification of risk factors associated with sharp score. Using these three methods, this study aims to: (a) sharp score exhibits diagnostic value for RA; and (b) analyze the role of effective factors as determinants of sharp score in RA.
Discussion
This study was a large-sample retrospective study, which has characterized sharp score and its effective factors in RA. The role of DAS28, clinical indicators, bone metabolism markers, and sociodemographic factors as determinants of sharp score was examined. Age, ESR, CRP, RF, IGA, IGG, IGM, C3, C4, BALP, BGP, OPG, RANKL, DAS28 were associated with sharp score. ESR, CRP, RF were also risk factors of sharp score.
Joint damage is very common in the early stage of RA, even within 2 years following disease onset in most patients (70–93%) [
17,
18]. Therefore, the probability of erosions occurring early in RA is adequately high [
8,
19]. Therefore, joint damage can trigger generate and maintain pain, which is a principle cause of disability and functional decline [
20]. The research conducted by Corbett et al. manifested that the occurrence of hand erosions in the first 2 years of RA was the strongest predictor of the dysfunction after 15 years [
21]. Early quantitative assessment of joint destruction and bone erosion are the first step to prevent or decrease its damage [
22,
23].
In spite of the lacking of a similar study so far depicting sharp score and its effective factors in RA, a few studies have described sharp score as an important observation index and effective factor of RA [
24]. LMAJansen followed early RA patients for 1 year, concluded that progression of these lesions was predicted by the number of radiographic lesions and Sharp/van der Heijde score [
12]. Similar findings were also observed in a cross-sectional research of RA patients with secondary SS (sSS) by Lindsay E. Brown et al., which found that RA patients with sSS exhibiting worse joint damage was associated with higher sharp score [
13]. As a part of our ongoing research on the joint destruction and bone erosion, in the present study we focused on sharp score, which might have significant diagnostic value for RA.
As reflected by analyses of Spearman correlation and Association rules, considerable positive correlations were noted between age, ESR, CRP, RF, IGA, IGG, IGM, C3, BALP, BGP, OPG, DAS28 and sharp score in our work. In addition, Logistic regression analysis elucidated ESR, CRP, and RF as risk factors for the sharp score. DAS28, clinical indicators, bone metabolism markers, and sociodemographic factors differences in sharp score outcomes remains enigmatic in the China and little has been known about the influence of sharp score. There are differences in sharp score of different genders, which showed that a higher sharp score of female patients compared to male [
25]. There are different explanations of these gender-based differences, which may be the biological progression of disorders and self-perception and reporting of symptoms [
26]. Higher DAS28, RF
+ and radiographic grading were also associated with sharp score, which can be attributable to its link to facilitated inflammation and comorbidities [
27,
28]. Symptom duration and smoking history could affect sharp score progression by changing medication adherence, health literacy, and self-care [
29,
30].
Several strengths exist in our study. Initially, our work is the first retrospective research of sharp score in RA patients in China, and has a unique position in ascertaining the effective factors of sharp score in China. Secondly, as we know, this is the only research so far that has utilized three methods to identify a significant correlation between sharp score and different variables. One of the limitations of our study was the lack of multi-center and inclusion of diverse ethnic/racial groups. Furthermore, the sample size in our research is small, which may limit the discovery of remarkable differences between sharp score and different variables. Additionally, we also need to study the diagnostic accuracy and importance of magnetic resonance imaging and take it into the next research.
There is no doubt that some limitations of the current study should be realized. Firstly, although the sample size of the current study is big, it yet derived from a single-center trail, where patients were all retrospectively enrolled. It’s necessary to validate and further explore the performance of sharp score in prospective cohorts nationwide or even worldwide. The lack of a validation cohort inevitably undermines the scientific power of our study. Secondly, patients included in our study may not be representative of the general RA population in China, hence a spectrum bias may exist here. Last but not least, we do admit that the multiple r values lower than 0.2 in this study could only indicate weak correlations, despite the statistical significances we observed. However, we also believe the large-scale profile of the current study could offer insights for future researches.
In conclusion, the study has characterized the correlation of sharp score with DAS28, clinical indicator, bone metabolism markers, and sociodemographic factors, and illustrated a significant correlation between sharp score and these variables. The demonstrated differences in joint damage and bone erosion in the early stage of RA may afflict the following long-term outcomes. During the early stage of the disease, differences in sharp score should be considered in developing treatment options when patients are mostly likely to benefit from interventions. This assumes a pivotal role in improvement of disease control and functional outcomes.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.